Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by SanFrancisco99on Mar 13, 2015 9:35pm
366 Views
Post# 23520353

RE:RE:Amazing Few Weeks: Winter Surprise for RVX

RE:RE:Amazing Few Weeks: Winter Surprise for RVXHi GV:   That's a good question of course.  I read that on Stockhouse, actually.  Somebody posted that the stock price needed to be above $2 for a NASDAQ listing to make sense.  I think it might have been Torpedoman... something he heard at the AGM I think.  Not 100% sure.

The stock price seems to be heading to north of $2 Canadian Dollars.  So maybe Torpedo is on to something there....  Maybe the big-boy investors in Calgary have decided it's time to send this little company to Nasdaq....   There are a lot of big boyz there who could do that if they wanted to.

I'm scratching my head as to the reasons behind this sustained rally.  I think there could be a lot of reasons for the rise.  The first event behind this rally this year was clearly the surprise reaching of Phase 3 status for the next trial.  That was something I had been hoping for, but didn't see coming for sure.  Not at all - but I held out hope for it.  It was a major event when it happened and I think it took a while for the market to appreciate what it meant.  I knew immediately, as I am sure others here on this board did.

As we learn additional details about the reMACE study, we seem to be getting more and more excited.  The key piece of info in this respect was its low cost.  But other pieces of information look good too.

Most recently, we learned that there could acually be THREE independent Phase 3 studies.  That's another big piece of info.... postiive stuff - as that increases the chances of getting this little piggy to market.  Not by a factor of 3 (since there is some risk shared between the 3 studies such as a safety risk in any trial)... but by a large factor I think nonetheless.  Getting to market looks much more likely now for this little piggy.

I see a lot of other potential drivers for stock price ahead.  This looks a lot to me like the run-up before the first dosing of ASSURE.  We had a sustained rise then.  Check the history on that and you'll see it.

And there was another such sustained rise as ASSURE reached its "end of dosing" and then results were announced.  Of course, once they were announced it went fast in a different direction as we all painfully know.  But the run-up to those dates was sustained and the stock price took a positive spin over those time periods.

Of course, this is all per my memory on the subject.  But it gives me a lot of comfort about what I think is going to happen between now and about the end of June.   And possibly all the way to the point when reMACE results are shared.

So we are in a new era.   One with less tossing and turning at night!!!

GLTA.  DYODD.  IMHO.



Bullboard Posts